Detalhe da pesquisa
1.
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocol.
Cancer
; 129(18): 2798-2807, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221679
2.
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.
BMC Cancer
; 22(1): 746, 2022 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804307
3.
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.
Lancet
; 393(10185): 2051-2058, 2019 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982687
4.
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients.
Breast Cancer Res Treat
; 183(2): 365-372, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632513
5.
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial.
BMC Cancer
; 19(1): 1206, 2019 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31829203
6.
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
BMC Cancer
; 19(1): 816, 2019 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31426760
7.
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.
Gynecol Oncol
; 154(1): 183-188, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31104905
8.
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer.
Breast Cancer Res Treat
; 172(2): 371-379, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30094551
9.
Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.
J Neurooncol
; 128(3): 431-6, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084705
10.
Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy.
Acta Oncol
; 54(3): 322-32, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25350526
11.
Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial.
BMC Cancer
; 14: 934, 2014 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25496482
12.
What is the predictive value of RECIST criteria following stereotactic lung radiation?
Radiother Oncol
; 190: 109976, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37918636
13.
PET/MRI Assessment of Acute Cardiac Inflammation 1 Month After Left-Sided Breast Cancer Radiation Therapy.
J Nucl Med Technol
; 51(2): 133-139, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192822
14.
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.
BMC Cancer
; 12: 305, 2012 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22823994
15.
The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial.
Thorac Cancer
; 13(13): 1898-1915, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35611396
16.
Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial.
Clin Transl Radiat Oncol
; 37: 145-152, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36275452
17.
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes.
Int J Radiat Oncol Biol Phys
; 114(4): 611-616, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643253
18.
Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled Trial.
Int J Radiat Oncol Biol Phys
; 113(5): 1072-1084, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550405
19.
Cost Minimization Analysis of Hypofractionated Radiotherapy.
Curr Oncol
; 28(1): 716-725, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33573158
20.
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical study.
Radiat Oncol
; 16(1): 11, 2021 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33441162